Willkie Farr & Gallagher LLP

Willkie Farr & Gallagher LLP

willkie.comwillkie.comwillkie.comClient Satisfaction

Lawyers

Daniel Gendron

Daniel Gendron

Work Department

Finance

Position

Daniel Gendron is a partner in Willkie’s Corporate & Financial Services Department and Finance Practice in London. He has extensive experience in leveraged finance transactions, hybrid capital, special situations and financial restructurings, as well as high yield bond issuances. He acts for a variety of borrowers (focusing on financial sponsors and their portfolio companies) and lenders (focusing on private capital providers, in particular hybrid capital and credit opportunities funds). He has wide-ranging experience in both new money and stressed/distressed financings, enabling him to deliver comprehensive and commercial advice to his clients.

Daniel has advised on significant matters including:

Platinum Equity on: the financing of its acquisition of Sunrise Medical, a world leader in advanced assistive mobility solutions, from Nordic Capital the financing of its acquisition of Imerys’ High Temperature Solutions business, the financing aspects of its acquisition of HarbisonWalker International, and the group’s subsequent refinancing Insight Partners on the financing aspects of its sale of a majority stake in AMCS, a global leader in performance and sustainability software, to EQT Private Equity IK Partners on its acquisition of a minority stake in A-SAFE, a leading manufacturer and distributor of industrial polymer safety barrier systems Searchlight Capital Partners on its recommended final cash offer for the entire share capital of London-listed Gresham House plc, a specialist alternative asset manager Investcorp Technology Partners in the financing of its acquisition of software solutions firm NetRom

Memberships

Daniel is an occasional speaker at Loan Markets Association conferences, speaking about topics such as leveraged inter-creditor terms and multi-layered capital structures.

Education

University of Ottawa, 2000

Mentions